Article

Identification of monitoring panels and hub genes for heterogeneous relapse outcomes in acute lymphoblastic leukemia

2026-04-23

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> Relapse is the leading cause of mortality in acute lymphoblastic leukemia (ALL) patients. Minimal residual disease (MRD) detection is effective for bone marrow relapse (BMR) but less so for central nervous system relapse (CR) and combined bone marrow-central nervous system relapse (BMCR). Furthermore, there remains an unmet need for more effective therapeutic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0fa14e31-c142-5b17-86b2-511479558564
DOI: 10.21203/rs.3.rs-8999580/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of monitoring panels and hub genes for heterogeneous relapse outcomes in acute lymphoblastic leukemiaDOI 10.21203/rs.3.rs-8999580/v1Read

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemiaSemantic proximity Read

MD-ALL: an integrative platform for molecular diagnosis of B-acute lymphoblastic leukemia.Semantic proximity Read

Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution.Semantic proximity Read

Mutations in epigenetic regulators are involved in acute lymphoblastic leukemia relapse following allogeneic hematopoietic stem cell transplantation.Semantic proximity Read

The machine-learning classifier ALLCatchR2 identifies 20 T-ALL subtypes across cohorts and age groupsSemantic proximity Read

Multi-Omics Analysis of Acute Lymphoblastic Leukemia Identified the Methylation and Expression Differences Between BCP-ALL and T-ALLSemantic proximity Read

PPARG, GNG12, and CD19 are potential independent predictors of central nerve recurrence in childhood acute lymphoblastic leukemiaSemantic proximity Read

MIR4435-2HG as a Novel Predictive Biomarker of Chemotherapy Response and Death in Pediatric B-cell AllSemantic proximity Read

NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients.Semantic proximity Read

Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 casesSemantic proximity Read

Identification and validation of hub genes and molecular classifications associated with chronic myeloid leukemiaSemantic proximity Read

Advances in the diagnosis and classification of B-ALL: comparative insights from updated guidelines.Semantic proximity Read